# If AbCellera Biologics moves, who benefits? How far does the value-chain ripple reach?
Canonical: https://valuechain.wiki/abcellera · Facet: ripple · Updated: 2026-10-09T16:08:10.423123+00:00 · Source: ValueChain.wiki (cited money-flow graph)

**Citable summary**: Per the valuechain.wiki graph, AbCellera Biologics is directly linked to 2 companies (0 supply, 2 revenue relationships) and reaches 6 companies within two hops; the links are backed by 14 dated sources, 6 of them primary filings (as of 2026-10-09).

AbCellera Biologics operates across NASDAQ, AI antibody discovery, pharma partnerships. It is up +234.2% in 2026. Its demand and supply links are known, but listed-counterparty return data is limited. A node selling discovery to pharma.

## Demand chain (leading)
- T1 Lilly (Eli) (https://valuechain.wiki/lilly-eli.md)
- T2 Cardinal Health, Inc. (https://valuechain.wiki/cardinal-health.md)
- T3 CVS Health (https://valuechain.wiki/cvs-health.md)
- T2 McKesson Corporation (https://valuechain.wiki/mckesson.md)
- T3 Walmart Inc (https://valuechain.wiki/walmart.md)
- T2 Cencora, Inc. (https://valuechain.wiki/cencora.md)
- T1 AbbVie (https://valuechain.wiki/abbvie.md)
- T2 Celltrion (https://valuechain.wiki/celltrion.md)

---
Full node: https://valuechain.wiki/abcellera.md · JSON: https://valuechain.wiki/abcellera.json